Medical Device News Magazine

Canon Medical Partners With Surfacide to Provide Rapid Decontamination Solution for Imaging Systems

UV-C Decontamination Technology Can Decontaminate Imaging Equipment of Viral Infectious Diseases in Minutes

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Hospitals and institutions are regularly using imaging as a frontline tool for triaging patients, and disinfection after use can be time-consuming when every second counts. To meet the need for fast decontamination, Canon Medical Systems USA, Inc. has partnered with Surfacide to offer Helios – a rapid decontamination tool for its imaging equipment.

The Surfacide Helios system provides an automated UV-C decontamination technology that significantly reduces bacteria, spores and viruses and is effective against a variety of advanced viral infectious diseases. Helios incorporates multiple automated UV-C emitters that work together to provide decontamination of the room in minutes to help improve workflow.

“At Canon Medical, our priority is to support our customers and their patients by providing them not only with innovative imaging systems, but also the latest technology advancements that can impact their outcomes and workflow,” said Satrajit Misra, vice president, Marketing and Strategic Development, Canon Medical Systems USA, Inc. “In the current healthcare climate, partnering with Surfacide to offer a solution that can quickly, easily and effectively decontaminate an imaging system can help hospitals and institutions manage their high throughput and keep patients safe by helping to prevent the spread of infection.”

“Today, two innovative technology leaders are focused on making imaging suites and hospitals safer for hospital healthcare workers and patients,” says Gunner Lyslo, Founder & CEO of Surfacide LLC. “Surfacide and Canon Medical are coming together at an urgent time when safety and infection prevention is paramount throughout the world. Surfacide and its multi-emitter UV-C technology will fight infectious diseases and decontaminate surfaces to create a much safer environment for patients and healthcare workers when it is needed the most.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”